Akebia Therapeutics (AKBA) P/S (2017 - 2026)
Akebia Therapeutics (AKBA) P/S from Jan 3, 2017 to Jul 20, 2026. The TTM Akebia Therapeutics (AKBA) P/S is 1.48. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/S
Annual P/S change of Akebia Therapeutics (AKBA)
| Year | P/S | Change |
|---|---|---|
| 2026 | 1.48 | -18.44% |
| 2025 | 1.81 | -32.16% |
| 2024 | 2.67 | +121.74% |
| 2023 | 1.20 | +235.85% |
| 2022 | 0.36 | -80.88% |
| 2021 | 1.87 | +33.40% |
| 2020 | 1.40 | -38.84% |
| 2019 | 2.30 | -47.48% |
| 2018 | 4.37 | -74.63% |
| 2017 | 17.23 | N/A |
Comparison Akebia Therapeutics (AKBA) P/S with competitors
Akebia Therapeutics (AKBA) P/S is 1.48.